Report Summary Catalogue Methodological

Definition and Scope:
Nanotechnology drug delivery systems involve the use of nanoscale materials to deliver therapeutic agents to specific cells within the body. These systems can enhance the efficacy and safety of drugs by improving their solubility, stability, and targeted delivery. Nanotechnology drug delivery systems encompass a wide range of technologies, including nanoparticles, liposomes, dendrimers, and micelles. These systems have the potential to revolutionize the field of medicine by enabling the precise delivery of drugs to target sites, reducing side effects, and improving patient outcomes.
The market for nanotechnology drug delivery systems is experiencing significant growth due to several key market trends and drivers. One of the primary trends driving market growth is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Nanotechnology drug delivery systems offer a promising solution for the treatment of these diseases by improving the bioavailability and therapeutic efficacy of drugs. Additionally, the growing demand for personalized medicine and targeted therapies is fueling the adoption of nanotechnology drug delivery systems, as they enable the customization of treatment regimens based on individual patient characteristics.
Furthermore, advancements in nanotechnology research and development are driving innovation in drug delivery systems, leading to the development of novel formulations with enhanced properties. The increasing investment in research and collaborations between pharmaceutical companies and academic institutions is also propelling market growth. Moreover, stringent regulatory guidelines and the need for safer and more effective drug delivery methods are further driving the adoption of nanotechnology drug delivery systems in the healthcare industry. In addition, the expanding geriatric population and the rising healthcare expenditure are expected to contribute to the growth of the market for nanotechnology drug delivery systems in the coming years.
The global Nanotechnology Drug Delivery Systems market size was estimated at USD 4685.99 million in 2024, exhibiting a CAGR of 2.50% during the forecast period.
This report offers a comprehensive analysis of the global Nanotechnology Drug Delivery Systems market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Nanotechnology Drug Delivery Systems market.
Global Nanotechnology Drug Delivery Systems Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Nanotechnology Drug Delivery Systems market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Nanotechnology Drug Delivery Systems Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
AbbVie
Inc.
Amgen Inc.
Celgene Corporation
Johnson & Johnson
Merck & Co.
Inc.
Novartis International AG
Perrigo Company plc
Pfizer
Inc.
Teva Pharmaceutical Industries Ltd.
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
Market Segmentation by Type
Nanocrystals
Nanoparticles
Dendrimers
Gold Nanoparticles
Fullerenes
Liposomes
Nanotubes
Others
Market Segmentation by Application
Immunology
Cardiovascular
Neurology
Oncology
Others
Geographic Segmentation North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Nanotechnology Drug Delivery Systems Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nanotechnology Drug Delivery Systems Market Definition
1.2 Nanotechnology Drug Delivery Systems Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
2 Executive Summary
2.1 Global Nanotechnology Drug Delivery Systems Market Size
2.2 Market Segmentation – by Type
2.3 Market Segmentation – by Application
2.4 Market Segmentation – by Geography
3 Key Market Trends, Opportunity, Drivers and Restraints
3.1 Key Takeway
3.2 Market Opportunities & Trends
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Major Factor Assessment
4 Global Nanotechnology Drug Delivery Systems Market Competitive Landscape
4.1 Global Nanotechnology Drug Delivery Systems Sales by Manufacturers (2020-2025)
4.2 Global Nanotechnology Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
4.3 Nanotechnology Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 New Entrant and Capacity Expansion Plans
4.5 Mergers & Acquisitions
5 Global Nanotechnology Drug Delivery Systems Market by Region
5.1 Global Nanotechnology Drug Delivery Systems Market Size by Region
5.1.1 Global Nanotechnology Drug Delivery Systems Market Size by Region
5.1.2 Global Nanotechnology Drug Delivery Systems Market Size Market Share by Region
5.2 Global Nanotechnology Drug Delivery Systems Sales by Region
5.2.1 Global Nanotechnology Drug Delivery Systems Sales by Region
5.2.2 Global Nanotechnology Drug Delivery Systems Sales Market Share by Region
6 North America Market Overview
6.1 North America Nanotechnology Drug Delivery Systems Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Nanotechnology Drug Delivery Systems Market Size by Type
6.3 North America Nanotechnology Drug Delivery Systems Market Size by Application
6.4 Top Players in North America Nanotechnology Drug Delivery Systems Market
7 Europe Market Overview
7.1 Europe Nanotechnology Drug Delivery Systems Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.1.6 Sweden Market Overview
7.1.7 Denmark Market Overview
7.1.8 Netherlands Market Overview
7.1.9 Switzerland Market Overview
7.1.10 Belgium Market Overview
7.1.11 Russia Market Overview
7.2 Europe Nanotechnology Drug Delivery Systems Market Size by Type
7.3 Europe Nanotechnology Drug Delivery Systems Market Size by Application
7.4 Top Players in Europe Nanotechnology Drug Delivery Systems Market
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Australia Market Overview
8.1.6 Indonesia Market Overview
8.1.7 Malaysia Market Overview
8.1.8 Philippines Market Overview
8.1.9 Singapore Market Overview
8.1.10 Thailand Market Overview
8.1.11 Rest of APAC Market Overview
8.2 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Type
8.3 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Application
8.4 Top Players in Asia-Pacific Nanotechnology Drug Delivery Systems Market
9 South America Market Overview
9.1 South America Nanotechnology Drug Delivery Systems Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Nanotechnology Drug Delivery Systems Market Size by Type
9.3 South America Nanotechnology Drug Delivery Systems Market Size by Application
9.4 Top Players in South America Nanotechnology Drug Delivery Systems Market
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Nanotechnology Drug Delivery Systems Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Nanotechnology Drug Delivery Systems Market Size by Type
10.3 Middle East and Africa Nanotechnology Drug Delivery Systems Market Size by Application
10.4 Top Players in Middle East and Africa Nanotechnology Drug Delivery Systems Market
11 Nanotechnology Drug Delivery Systems Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Nanotechnology Drug Delivery Systems Sales Market Share by Type (2020-2033)
11.3 Global Nanotechnology Drug Delivery Systems Market Size Market Share by Type (2020-2033)
11.4 Global Nanotechnology Drug Delivery Systems Price by Type (2020-2033)
12 Nanotechnology Drug Delivery Systems Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Nanotechnology Drug Delivery Systems Market Sales by Application (2020-2033)
12.3 Global Nanotechnology Drug Delivery Systems Market Size (M USD) by Application (2020-2033)
12.4 Global Nanotechnology Drug Delivery Systems Sales Growth Rate by Application (2020-2033)
13 Company Profiles
13.1 AbbVie
13.1.1 AbbVie Company Overview
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Nanotechnology Drug Delivery Systems Major Product Offerings
13.1.4 AbbVie Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.1.5 Key News
13.2 Inc.
13.2.1 Inc. Company Overview
13.2.2 Inc. Business Overview
13.2.3 Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
13.2.4 Inc. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.2.5 Key News
13.3 Amgen Inc.
13.3.1 Amgen Inc. Company Overview
13.3.2 Amgen Inc. Business Overview
13.3.3 Amgen Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
13.3.4 Amgen Inc. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.3.5 Key News
13.4 Celgene Corporation
13.4.1 Celgene Corporation Company Overview
13.4.2 Celgene Corporation Business Overview
13.4.3 Celgene Corporation Nanotechnology Drug Delivery Systems Major Product Offerings
13.4.4 Celgene Corporation Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.4.5 Key News
13.5 Johnson and Johnson
13.5.1 Johnson and Johnson Company Overview
13.5.2 Johnson and Johnson Business Overview
13.5.3 Johnson and Johnson Nanotechnology Drug Delivery Systems Major Product Offerings
13.5.4 Johnson and Johnson Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.5.5 Key News
13.6 Merck and Co.
13.6.1 Merck and Co. Company Overview
13.6.2 Merck and Co. Business Overview
13.6.3 Merck and Co. Nanotechnology Drug Delivery Systems Major Product Offerings
13.6.4 Merck and Co. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.6.5 Key News
13.7 Inc.
13.7.1 Inc. Company Overview
13.7.2 Inc. Business Overview
13.7.3 Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
13.7.4 Inc. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.7.5 Key News
13.8 Novartis International AG
13.8.1 Novartis International AG Company Overview
13.8.2 Novartis International AG Business Overview
13.8.3 Novartis International AG Nanotechnology Drug Delivery Systems Major Product Offerings
13.8.4 Novartis International AG Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.8.5 Key News
13.9 Perrigo Company plc
13.9.1 Perrigo Company plc Company Overview
13.9.2 Perrigo Company plc Business Overview
13.9.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Major Product Offerings
13.9.4 Perrigo Company plc Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.9.5 Key News
13.10 Pfizer
13.10.1 Pfizer Company Overview
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Nanotechnology Drug Delivery Systems Major Product Offerings
13.10.4 Pfizer Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.10.5 Key News
13.11 Inc.
13.11.1 Inc. Company Overview
13.11.2 Inc. Business Overview
13.11.3 Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
13.11.4 Inc. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.11.5 Key News
13.12 Teva Pharmaceutical Industries Ltd.
13.12.1 Teva Pharmaceutical Industries Ltd. Company Overview
13.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
13.12.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Major Product Offerings
13.12.4 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.12.5 Key News
13.13 3M
13.13.1 3M Company Overview
13.13.2 3M Business Overview
13.13.3 3M Nanotechnology Drug Delivery Systems Major Product Offerings
13.13.4 3M Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.13.5 Key News
13.14 Zosano Pharma
13.14.1 Zosano Pharma Company Overview
13.14.2 Zosano Pharma Business Overview
13.14.3 Zosano Pharma Nanotechnology Drug Delivery Systems Major Product Offerings
13.14.4 Zosano Pharma Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.14.5 Key News
13.15 Becton-Dickinson（BD）Technologies
13.15.1 Becton-Dickinson（BD）Technologies Company Overview
13.15.2 Becton-Dickinson（BD）Technologies Business Overview
13.15.3 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
13.15.4 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.15.5 Key News
13.16 Nanopass Technologies
13.16.1 Nanopass Technologies Company Overview
13.16.2 Nanopass Technologies Business Overview
13.16.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
13.16.4 Nanopass Technologies Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.16.5 Key News
13.17 Corium
13.17.1 Corium Company Overview
13.17.2 Corium Business Overview
13.17.3 Corium Nanotechnology Drug Delivery Systems Major Product Offerings
13.17.4 Corium Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.17.5 Key News
13.18 Valeritas
13.18.1 Valeritas Company Overview
13.18.2 Valeritas Business Overview
13.18.3 Valeritas Nanotechnology Drug Delivery Systems Major Product Offerings
13.18.4 Valeritas Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.18.5 Key News
13.19 Nitto
13.19.1 Nitto Company Overview
13.19.2 Nitto Business Overview
13.19.3 Nitto Nanotechnology Drug Delivery Systems Major Product Offerings
13.19.4 Nitto Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.19.5 Key News
13.20 Microdermics
13.20.1 Microdermics Company Overview
13.20.2 Microdermics Business Overview
13.20.3 Microdermics Nanotechnology Drug Delivery Systems Major Product Offerings
13.20.4 Microdermics Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.20.5 Key News
13.21 TheraJect
13.21.1 TheraJect Company Overview
13.21.2 TheraJect Business Overview
13.21.3 TheraJect Nanotechnology Drug Delivery Systems Major Product Offerings
13.21.4 TheraJect Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.21.5 Key News
13.22 Vaxxas
13.22.1 Vaxxas Company Overview
13.22.2 Vaxxas Business Overview
13.22.3 Vaxxas Nanotechnology Drug Delivery Systems Major Product Offerings
13.22.4 Vaxxas Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.22.5 Key News
13.23 Lohmann Therapie-Systeme AG
13.23.1 Lohmann Therapie-Systeme AG Company Overview
13.23.2 Lohmann Therapie-Systeme AG Business Overview
13.23.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Major Product Offerings
13.23.4 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Sales and Revenue fromNanotechnology Drug Delivery Systems (2020-2025)
13.23.5 Key News
14 Key Market Trends, Opportunity, Drivers and Restraints
14.1 Key Takeway
14.2 Market Opportunities & Trends
14.3 Market Drivers
14.4 Market Restraints
14.5 Market Major Factor Assessment
14.6 Porter's Five Forces Analysis of Nanotechnology Drug Delivery Systems Market
14.7 PEST Analysis of Nanotechnology Drug Delivery Systems Market
15 Analysis of the Nanotechnology Drug Delivery Systems Industry Chain
15.1 Overview of the Industry Chain
15.2 Upstream Segment Analysis
15.3 Midstream Segment Analysis
15.3.1 Manufacturing, Processing or Conversion Process Analysis
15.3.2 Key Technology Analysis
15.4 Downstream Segment Analysis
15.4.1 Downstream Customer List and Contact Details
15.4.2 Customer Concerns or Preference Analysis
16 Conclusion
17 Appendix
17.1 Methodology
17.2 Research Process and Data Source
17.3 Disclaimer
17.4 Note
17.5 Examples of Clients
17.6 Disclaimer

Research Methodology
The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.

Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.

Research Process
The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research.
Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).